Navigation Links
Precision for Medicine Acquires Precision Health Economics

BETHESDA, Md. and LOS ANGELES, April 16, 2015 /PRNewswire/ -- Precision for Medicine, a specialized services company supporting next-generation approaches to drug development and commercialization, today announced the acquisition of Precision Health Economics (PHE). A world-renowned and cutting-edge health economics consultancy and analytics firm, PHE leverages the expertise of policy analysts, economists, clinicians, and academics to advance research on the most complex healthcare questions. Life sciences companies and policymakers worldwide turn to PHE to shape strategy, inform key healthcare decisions, and produce effective changes in policy through innovative research.

PHE, headquartered in Los Angeles, CA, was founded by Drs. Dana Goldman, Darius Lakdawalla, and Tomas Philipson, professors at the University of Southern California and the University of Chicago. PHE's network of academic experts includes numerous nationally and globally recognized scholars in health economics, medicine, and health policy. The team also includes former leaders at the Centers for Medicare and Medicaid Services, the Food and Drug Administration, the Department of the Treasury, the Congressional Budget Office, and the President's Council of Economic Advisers.

"Precision Health Economics is the leader in developing innovative approaches to the science of value. Their work impacts policy and influences payment systems across some of the most important and fastest growing sectors of medicine," said Ethan Leder, chairman, Precision for Medicine. "Adding PHE's differentiated capabilities fortifies our approach to helping life sciences companies deliver more effective treatments to patients in the era of precision medicine by integrating research, analytics, science, and communications. The PHE management team will remain in place and will continue to focus on their customers in the pharmaceutical and life sciences markets."

"In the age of personalized medicine, it's vitally important to understand not only how value derives from tailored treatment, but also how to navigate the data, analytics, and policy challenges associated with precision medicine," said Dana Goldman, co-founder, Precision Health Economics. "The combination of Precision Health Economics and Precision for Medicine is uniquely suited to meet these challenges," Goldman added. "This acquisition provides us access to a pool of talent, knowledge, and expertise in the healthcare payer marketplace that will provide our clients deeper insights into the scope and scale of economic evidence required to shape future policy decisions," commented Glenn Bilawsky, who will serve as President of PHE.

This acquisition will expand the existing health economics and outcomes research (HEOR) capabilities of Precision for Value, a business unit of Precision for Medicine. Precision for Value excels in helping pharmaceutical and life sciences companies demonstrate and communicate the value of innovative medications. Through real-world expertise, and with recognized industry thought leaders and advanced analytic tools, the company's clients achieve an in-depth understanding of the specific drivers and barriers that impact market access. The acquisition extends the leadership in HEOR with a focus on innovative approaches to evidence generation.

About Precision Health Economics
Precision Health Economics integrates deep technical expertise with practical insights to bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in healthcare. In addition to its world-renowned team of health economists, PHE draws on the expertise of a network of affiliated academic scientists and clinicians from the world's leading universities, straddling the policy and clinical arenas to reach top decision makers and influence outcomes. The company has offices in Austin, TX, Boston, MA, Los Angeles, CA, and Oakland, CA.  For more information, go to

About Precision for Medicine
Formed in 2012, Precision for Medicine is a specialized services company supporting next generation approaches to drug development and commercialization. It provides integrated services and infrastructure to support pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. Precision for Medicine brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD, with offices in Cambridge, MA, Chicago, IL, Frederick, MD, Gladstone, NJ, Indianapolis, IN, New York, NY, and Stamford, CT. For more information, visit

SOURCE Precision for Medicine
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision for Medicine Adds Regulatory Expertise To Support Next Generation Medicines
2. Quartz Bio SA Supports Debiopharm Group Precision Medicine Bioinformatics
3. World Molecular Imaging Congress to Feature Scientific Breakthroughs in Molecular Multimodal Imaging Essential to Precision Medicine
4. Technology Innovation Provides Catalyst for Scientific Breakthroughs in Precision Medicine at World Molecular Imaging Congress
5. TechPrecision Corporation Schedules Conference Call to Report Fiscal 2014 Second Quarter Financial Results
6. Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application
7. Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
8. Clinical Performance of Trovagenes Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium
9. Clinical Study Using Trovagenes Precision Cancer Monitoring Platform Published in Cancer Discovery
10. Precision for Medicine Awarded NIH Contract Valued at $28 Million
11. MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis
Post Your Comments:
(Date:12/2/2019)... ... December 02, 2019 , ... Strong public health departments ... learn, and play. Striving to fulfill their crucial mission, more and more health ... by the Public Health Accreditation Board (PHAB). Today, PHAB announced it has awarded ...
(Date:11/30/2019)... Fla. (PRWEB) , ... November 29, 2019 , ... ACC ... This long awaited expansion was due to Amazon’s incredibly large purchase of ... had been delayed by Mercedes, they’ve recently received word on vehicle availability and are ...
(Date:11/27/2019)... (PRWEB) , ... November 27, 2019 , ... Chris Draft ... him for the news he and girlfriend, Keasha, received when Keasha, a never-smoker, was ... to fight back, and 8 years ago today, standing hand-in-hand, they launched Team Draft, ...
Breaking Medicine Technology:
(Date:11/30/2019)... ROSA, Calif. (PRWEB) , ... November 29, 2019 , ... ... of the year across their family of brands—Gorilla Grow Tent, Kind LED Grow Lights, ... save 40% on the Original 5’x5’ Gorilla Grow Tent . The best-selling grow ...
(Date:11/27/2019)... (PRWEB) , ... November 27, 2019 , ... AltMed ... (source: OMMU), has announced the grand opening of its newest MÜV™ Medical ... Florida Avenue in Lakeland. , AltMed’s eleventh MÜV Dispensary in Florida, is located on ...
(Date:11/23/2019)... ... ... HolistaPet, a leading CBD manufacturer for pets, today announced a new line ... CBD Pellets for Horses . The line of horse products contains all-natural, plant-based ... , “We are truly excited to bring the amazing benefits of our CBD products ...
(Date:11/22/2019)... ... November 22, 2019 , ... Nextremity Solutions, Inc., a strategic ... Capital of the World,” Warsaw, Ind., recently completed the first several cases using ... The InCore Lapidus System is a three-part construct intended for internal fixation for ...
(Date:11/22/2019)... ... , ... Benchmark Senior Living , a human connection company and leading ... named one of the Top Places to Work for the 12th straight year in ... to have made the list every year it has been published and is the ...
Breaking Medicine News(10 mins):